These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31215293)

  • 1. A review on parenteral delivery of peptides and proteins.
    Jain D; Mahammad SS; Singh PP; Kodipyaka R
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1403-1420. PubMed ID: 31215293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in protein and peptide parenteral delivery approaches.
    Patel A; Cholkar K; Mitra AK
    Ther Deliv; 2014 Mar; 5(3):337-65. PubMed ID: 24592957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.
    Bak A; Leung D; Barrett SE; Forster S; Minnihan EC; Leithead AW; Cunningham J; Toussaint N; Crocker LS
    AAPS J; 2015 Jan; 17(1):144-55. PubMed ID: 25398427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal iontophoresis. Part II: Peptide and protein delivery.
    Pillai O; Nair V; Poduri R; Panchagnula R
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):229-40. PubMed ID: 10389126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal delivery of proteins and peptides.
    Swaminathan J; Ehrhardt C
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1489-503. PubMed ID: 23092138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manufacturing techniques and excipients used during the design of biodegradable polymer-based microspheres containing therapeutic peptide/protein for parenteral controlled drug delivery.
    Tamilvanan S; Venkatesh Babu R; Kannan K; Basu SK; Sa B
    PDA J Pharm Sci Technol; 2008; 62(2):125-54. PubMed ID: 18540538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
    Shoyele SA; Slowey A
    Int J Pharm; 2006 May; 314(1):1-8. PubMed ID: 16563674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production methods and stabilization strategies for polymer-based nanoparticles and microparticles for parenteral delivery of peptides and proteins.
    Teekamp N; Duque LF; Frijlink HW; Hinrichs WL; Olinga P
    Expert Opin Drug Deliv; 2015 Aug; 12(8):1311-31. PubMed ID: 25601515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein and peptide parenteral controlled delivery.
    Pawar R; Ben-Ari A; Domb AJ
    Expert Opin Biol Ther; 2004 Aug; 4(8):1203-12. PubMed ID: 15268656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
    Wang Y; Grainger DW
    Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of lipidation in the development of advanced protein and peptide therapeutics.
    Menacho-Melgar R; Decker JS; Hennigan JN; Lynch MD
    J Control Release; 2019 Feb; 295():1-12. PubMed ID: 30579981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Nanotechnology in Delivery of Protein and Peptide Drugs.
    Patil S; Vhora I; Amrutiya J; Lalani R; Misra A
    Curr Pharm Des; 2015; 21(29):4155-73. PubMed ID: 26323432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral protein formulations: An overview of approved products within the European Union.
    Gervasi V; Dall Agnol R; Cullen S; McCoy T; Vucen S; Crean A
    Eur J Pharm Biopharm; 2018 Oct; 131():8-24. PubMed ID: 30006246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.
    Brayden DJ; Hill TA; Fairlie DP; Maher S; Mrsny RJ
    Adv Drug Deliv Rev; 2020; 157():2-36. PubMed ID: 32479930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel delivery technologies for protein and peptide therapeutics.
    Kumar TR; Soppimath K; Nachaegari SK
    Curr Pharm Biotechnol; 2006 Aug; 7(4):261-76. PubMed ID: 16918403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
    Andrade F; Videira M; Ferreira D; Sarmento B
    Nanomedicine (Lond); 2011 Jan; 6(1):123-41. PubMed ID: 21182424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the delivery of peptide drugs: an industry perspective.
    Lewis AL; Richard J
    Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of freeze-drying in the development of oral drug delivery systems.
    Siow CR; Wan Sia Heng P; Chan LW
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1595-1608. PubMed ID: 27267745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances and opportunities in delivery of therapeutic proteins and peptides.
    Banakar UV
    J Biomater Appl; 1997 Apr; 11(4):377-429. PubMed ID: 9178093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.